SigTuple has successfully raised approximately USD 19 million in Series B funding to enhance its AI-driven diagnostics solutions, aimed at improving healthcare accessibility and accuracy in India.

Target Information

SigTuple is an innovative company focused on making routine medical screening and pathology tests more accessible, affordable, and accurate. It harnesses advanced technologies such as robotics, artificial intelligence (AI), and cloud computing to optimize medical diagnostics. Since its inception, SigTuple has developed its flagship product, 'Manthana', which acts as a continuous learning platform that ingests and processes visual medical data to generate insightful intelligence, significantly improving diagnostic capabilities.

Founded by Rohit, Apurv, and Tathagato, the team at SigTuple comprises 90 specialists, including doctors, data scientists, and robotics engineers, who collectively work on various R&D projects. Their collaborative efforts have resulted in the development of innovative devices, such as the AI100, which digitizes biological samples and produces test reports using cloud-based AI software.

Industry Overview

The global healthcare industry faces significant challenges regarding the accessibility, affordability, and accuracy of basic medical services. The standard doctor-to-patient ratio globally is approximately 1.2:1000, with around 400 mill